Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure
Related Experiment Video
Updated: May 13, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Rumiko Izumi1, Tetsuya Niihori, Yoko Aoki
1Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan.
Abstract:
Myofibrillar myopathy (MFM) is a group of chronic muscular disorders that show the focal dissolution of myofibrils and accumulation of degradation products. The major genetic basis of MFMs is unknown. In 1993, our group reported a Japanese family with dominantly inherited cytoplasmic body myopathy, which is now included in MFM, characterized by late-onset chronic progressive distal muscle weakness and early respiratory failure. In this study, we performed linkage analysis and exome sequencing on these patients and identified a novel c.90263G>T mutation in the TTN gene (NM_001256850). During the course of our study, another groups reported three mutations in TTN in patients with hereditary myopathy with early respiratory failure (HMERF, MIM #603689), which is characterized by overlapping pathologic findings with MFMs. Our patients were clinically compatible with HMERF. The mutation identified in this study and the three mutations in patients with HMERF were located on the A-band domain of titin, suggesting a strong relationship between mutations in the A-band domain of titin and HMERF. Mutation screening of TTN has been rarely carried out because of its huge size, consisting of 363 exons. It is possible that focused analysis of TTN may detect more mutations in patients with MFMs, especially in those with early respiratory failure.
Insights
A novel mutation in the TTN gene was identified in a family with myofibrillar myopathy (MFM). This finding links TTN gene mutations to hereditary myopathy with early respiratory failure (HMERF).
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Myofibrillar myopathy (MFM) encompasses chronic muscle disorders with myofibril dissolution, but its genetic causes remain largely unknown.
- A previously reported Japanese family exhibited dominantly inherited cytoplasmic body myopathy, now classified under MFM, with late-onset distal weakness and early respiratory failure.
Purpose of the Study:
- To identify the genetic basis of myofibrillar myopathy in a Japanese family with a history of dominant inheritance.
- To investigate the potential role of the TTN gene in the pathogenesis of MFM and related neuromuscular disorders.
Main Methods:
- Linkage analysis was performed on affected family members.
- Exome sequencing was utilized to identify causative mutations.
- Mutation screening of the TTN gene was conducted.
Main Results:
- A novel mutation, c.90263G>T, was identified in the TTN gene (NM_001256850) in the studied family.
- The identified mutation and previously reported TTN mutations associated with hereditary myopathy with early respiratory failure (HMERF) are located in the A-band domain of titin.
- Clinical presentation of the patients was consistent with HMERF.
Conclusions:
- Mutations in the TTN gene, particularly in the A-band domain, are strongly associated with hereditary myopathy with early respiratory failure (HMERF).
- The TTN gene should be considered in the genetic analysis of patients with myofibrillar myopathies, especially those presenting with early respiratory failure.
- Focused analysis of the large TTN gene may reveal additional mutations in MFM patients.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
ATP Synthase: Mechanism
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...

